Read + Share
Iizuka K, Baxter M, Watanabe D, Yabe D, et al. Benefit of insulin glargine/lixisenatide for reducing residual hyperglycaemia in
Japan: Post hoc analysis of the LixiLan JP-O2 trial. Diabetes Obes Metab 2021;23:2795-2803.
PMID: 34472693
|
 |
|
Iizuka K, Baxter M, Watanabe D, Yabe D, et al. Benefit of insulin glargine/lixisenatide for reducing residual hyperglycaemia in
Japan: Post hoc analysis of the LixiLan JP-O2 trial. Diabetes Obes Metab 2021;23:2795-2803.
PMID: 34472693
|
|
|
|